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INTRODUCTION

Background on Dextromethorphan

Dextromethorphan (3-methoxy-17-methylmorphinan, DM) is the
dextrorotatory isomer of levomethorphan, a codeine analog of the morphinan
derivative levorphanol (Holtzman, 1994). At low doses DM is an effective antitussive
that lacks most opioid-like activity and is considered to be a safe over-the-counter
(OTC) cough suppressant (Jaffe & Martin, 1990). Higher doses of DM have been
studied for treating pain and various acute and chronic neurodegenerative conditions
but DM is rarely used for these purposes (Ikjaer, Dirks, Brennum, Wernberg, & Dahl,
1997; Nickelson, Hays & Balster., 1999). In large part, this is because high doses
produce unwanted effects that are similar to those produced by phencyclidine (PCP),
which is a dissociative anesthetic (Dematteus, Lallement, & Mallaret, 1998; Jasinski,
Martin, & Maski., 1971; Kim et al., 1996).
DM is considered to have abuse potential. For example, episodic and sporadic
abuse of DM by humans has been reported in several areas of the world and, because
of its availability, its abuse is most likely to occur among adolescents and young adults
(Cranston and Yoast, 1999). Also, Bem and Peck (1992) reported 64 cases of DM
dependence. Furthermore, Nevin (2004) reported 100,000 annual exposures due to
recreational use of DM among children less than 18 years of age in the United States
and approximately 60 deaths per year that can be directly linked to the drug.
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Reported effects of high doses of DM in humans include agitation, confusion,
slurred speech, ataxia, increased perceptual awareness, euphoria, altered time
perception, floating sensations, unusual facial movements, as well as tactile, auditory
and visual hallucinations (Darobe, 1996; Darobe, Keenan, & Richards, 1996; Nairn &
Diaz; 2001; Wolf & Caravati, 1995). Other reported effects include mild drunkenness,
delusions, paranoia, nervousness, and dysphoria. As noted previously, the subjective
effects of DM reported by humans are similar to those of PCP (Darobe, et al., 1996;
Dematteis et al., 1998; Golaszewski, 2004; Holtzman, 1982; Jasinski et al., 1971;
Price & Lebel, 2000; Wu, Otton, Kalow, & Sellers, 1995). Research with nonhumans
using drug discrimination procedures provides further evidence that DM and PCP
produce similar subjective effects (Holtzman, 1980, 1982; Nicholson, Hayes &
Balster, 1999).
The PCP-like effects of DM are most likely produced by its active metabolite,
dextrorphan (DR). While DM binds with low affinity to the PCP channel-site of the
NMDA receptor, DR binds with high affinity to that site (Nicholson et al., 1999).
PCP-like dugs have been shown to produce hyperlocomotion, stereotyped behavior,
and ataxia in rodents. For example, Dematteis et al., (1998) examined the effects of
20, 30, and 40 mg/kg DM and DR on rats’ locomotor activity, stereotyped behavior,
and ataxia in open-field experiments. DR at 40 mg/kg significantly increased
locomotor activity and stereotyped behavior while DM and lower doses of DR did not.
DM at 40 mg/kg produced slight ataxia while DR at 30 and 40 mg/kg produced
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moderate levels of ataxia. Therefore, DR induced PCP-like behavioral effects while
DM did not.
The present study examined the acute effects of dextromethorphan on rats
exposed to a learning assay that involved the acquisition of lever-press responding
with delayed reinforcement. Byrne, Baker & Poling (2000) suggested that a druginduced disruption of the initial acquisition of operant behavior “would be significant
in human users, many of whom are young and in the process of acquiring new
behaviors” (p. 501). Since DM is found in OTC preparations that are easily acquired
by adolescents and young adults, research examining the effects of this drug on the
acquisition of learning is warranted. Previous studies have examined the effects of
chlorpromazine (Byrne, LeSage, & Poling, 1997; Stolerman, 1971a, 1971b),
chlordiazepoxide (Stolerman, 1971a, 1971b), d-amphetamine (LeSage, Byrne, &
Poling, 1996), pyridostigmine bromide, and permethrin (Van Haaren et al., 1999; Van
Haaren et al., 2000), 3,4-methylenedioxymethamphetamine (MDMA) (Byrne et al.,
2000), and gamma-hydroxybutyrate (GHB) (Laraway, Snycerski, Baker, & Poling,
2004) on the acquisition of behavior with immediate and delayed reinforcement. The
effects of DM and other opioids on the acquisition of behavior with delayed
reinforcement have not been studied.
Other research methods have been used to study the influence of DM on the
acquisition of learning. Sierocinska, Nikolaev, Danysz, & Kacamarek (1991) and
Murata & Kawasaki (1993) examined the effects of DM on a passive avoidance task
and Dematteis et al. (1998) and Bane, Rojas, Indermaur, Bennett, and Avery (1996)
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studied the effects of DM on performance on several water-maze tasks. However,
these assays examined negatively reinforced behavior and the effects of DM on the
acquisition of positively reinforced behavior have not been examined.

Research on the Effects of Dextromethorphan on Learning

Few studies have examined the behavioral effects of DM in laboratory animals.
The drug has been shown to disrupt negatively reinforced spatial learning memory in a
passive avoidance task (Murata & Kawasaki 1993; Sierocinska et al., 1991), cue
learning, place learning, spatial learning, place recall working memory and reference
memory on water maze tasks (Bane et al., 1996; Dematteis et al., 1998), and positively
reinforced schedule-controlled behavior (Taskin, 1986).
Taskin (1986) trained rats to lever press for milk under a fixed-interval 45 s
schedule of reinforcement. Dose-dependent decreases in response rate were observed
after intramuscular injections of DM (0, 10, 20 and 40 mg/kg). The author also
showed that injections of naloxone (0.1 and 1.0 mg/kg) potentiated the rate-reducing
effects of DM. This is an interesting finding, because naloxone had previously been
shown to attenuate the effects of opioid agonists, but increase the effects of PCP on
schedule-controlled behavior (Wagner, Masters, & Tomie, 1984).
Sierocinska et al. (1991) examined the effects of intraperitoneal (IP) injections
of DR in rats performing a passive avoidance task. Subjects were placed in a twocompartment chamber after IP injections of DR (0, 3, 11, and 22 mg/kg). The safe
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compartment was larger and painted white while the compartment that delivered
electric shock was smaller and painted dark. Rats were placed in the white
compartment and as soon as they entered the dark compartment a guillotine door was
closed and the subjects were exposed to five brief footshocks. Immediately after the
shocks were delivered the subjects were placed in the white compartment and latency
to enter the dark compartment was recorded. Two days later, the subjects were
placed in the white compartment after being injected with the same dose of DR as they
had received on the first day and latency to enter the dark compartment was again
measured. The authors found that, for the subjects exposed to DR, latency to enter
the dark chamber was not significantly different than the control group for the trial that
immediately followed exposure to shock. However, two days after the initial training
session, the group of subjects exposed to DR at 22 mg/kg entered the dark chamber
significantly earlier than control subjects. The results indicated that DR disrupts longterm memory without harming short-term memory.
Murata and Kawasaki (1993) used a one-trial passive avoidance task with the
training and testing sessions separated by 24 h to examine the effects of injecting DM
and other NMDA antagonists (D-2-amino-phosphonovaleric acid, (+/-)-3-(2carboxypiperazin-4-yl)-propyl-1-phosphonic acid, 2-amino-4,5-(1,2-cyclohexyl)-7phosphonoheptanoic acid, 7-Cl kynurenate, ifenprodil, PCP, MK-801, ketamine, (+/-)N-allylnormetazocine, DM, ZnCl2, and MgCl2) into the ventricles of rats. The
minimum concentration of DM that produced significant disruptions was 250 nmol/rat.
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The drug also produced a reduction in muscle tone, a decrease in the number of
rearings, motor incoordination, and a decrease in locomotor activity.
DM has been shown to disrupt spatial learning. Bane et al. (1996) examined
the effects of IP injections of DM (10, 20, 30, and 40 mg/kg) on rats’ performance in a
Morris water maze. The Morris water maze is a circular container filled with water
that is made opaque by adding some form of nontoxic dye. A small escape platform
that rises to 1 cm beneath the surface of the water is placed in the container and the
amount of time it takes for the rat to find the escape platform is measured (e.g.,
Compton, Dietrich, & Smith, 1997; Eichenbaum, Stewart, & Morris, 1990). Bane et
al. (1996) divided the container into four equal quadrants and placed the escape
platform in one of those quadrants for the initial training session. Reversal training
involved changing the escape platform location to the quadrant opposite the one used
in initial training. The authors found that DM produced dose-dependent disruptions
during the initial training phase and during the initial retraining session when platform
location was changed. The authors also found that during reversal training rats
injected with the highest dose of DM (40 mg/kg) perseverated to the former location
longer than the other groups. In summary, DM impaired spatial learning in the Morris
water maze in a dose-dependent fashion.
Dematteis et al. (1998) examined the effects of DM (20, 30, and 40 mg/kg)
and its active metabolite DR (5, 10, and 15 mg/kg) on cue learning, place learning,
spatial learning, place recall working memory, and reference memory by investigating
performance on water maze tasks. Cue learning was examined by placing rats in the
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pool for five daily sessions and measuring the average time it took for them to reach
an emerged platform placed in the middle of the tank. The rats started from the same
position on each day. A final session was conducted five hours after the last injection
to assess the duration of drug effects. The escape latencies for rats injected with DR
at 10 and 15 mg/kg were significantly longer than control subjects. Performance was
not significantly impaired when compared to control subjects for the session
conducted 5 h after injection.
For the place learning procedure milk was added to make the water opaque
and the platform was submerged in one quadrant of the pool. The platform location
was fixed but the starting point varied across sessions. DM at 40 mg/kg and DR 10
and 15 mg/kg significantly increased escape latencies, but the lower doses of DM and
DR did not. One day after the last place-learning session the rats were placed in the
quadrant opposite the training quadrant without the platform present and allowed to
swim for 60 s. There were no significant differences in the amount of time various
group spent in the training quadrant. The place recall procedure evaluated the effects
of drugs on previously acquired spatial learning so drug sessions were conducted one
day after place learning without drug. No dose of either drug produced significant
effects on place learning. The working memory procedure looked at performance on
twice daily sessions over four days. The platform location remained the same within
days but was changed across days. The authors reported a slight disruptive effect of
DR at 15 mg/kg. These findings represent PCP-like effects of DR on learning and
working memory.
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Research on the Acquisition of Behavior with Immediate and Delayed
Reinforcement

Developments in the study of response acquisition with delayed reinforcement
have offered a sensitive and fruitful measure to study the effects of various drugs on
the acquisition of behavior (including chlorpromazine, d-amphetamine,
pyridostigmine bromide, permethrin, MDMA and GHB) (Byrne et al., 1997; LeSage
et al., 1996; Van Haaren et al., 1999; Van Haaren et al., 2000; Byrne et al., 2000;
Laraway et al., 2004). Although there have been many variations in the response
acquisition procedure, experimental sessions are typically preceded by a magazine
training session where subjects are placed in an experimental chamber containing no
operandum and where food delivery is not dependent on the subject’s behavior. For
the experimental session, subjects are placed in the chamber containing one or more
operandi where responses are immediately reinforced (fixed ratio 1, FR 1 schedule)
or responses are reinforced after a delay (e.g., tandem fixed-ratio 1 fixed time 30 s)
(e.g., Byrne et al., 1998; Lattal & Gleeson, 1990; Snycerski, Laraway, Byrne &
Poling, 1999; Stolerman, 1971a, 1971b; Sutphin, Byrne & Poling, 1998; Wilkenfield,
Nickel, Blakely, & Poling, 1992).
Neuringer (1970) showed that experimentally naïve pigeons acquire a keypeck response on an FR 1 schedule of reinforcement after magazine training, without
any form of shaping. Stolerman (1971a) examined the effects of injections of
chlorpromazine and chlordiazepoxide on rats’ acquisition of a lever press with
immediate reinforcement. He found that rats injected with chlorpromazine and
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chlordiazepoxide before experimental sessions experienced a delay in the acquisition
of a lever pressing response and emitted fewer total responses compared to rats that
received injections of saline. The aforementioned results suggest that the acquisition
of behavior might be helpful in the analysis of the effects of drugs.
Lattal and Gleeson (1990) extended previous research by examining three
different variations of the response-acquisition procedure. First, the authors
examined the acquisition of behavior using rats and pigeons. Second, they studied
acquisition of behavior with delayed consequences. Finally, because the close
proximity of the response operandum to the food delivery device may enhance the
acquisition of a response, the operandum was placed on the opposite side of the
chamber from the food hopper (for pigeons) or the food cup (for rats).
Subjects were first exposed to a variable-time (VT) 30-s schedule of food
delivery followed by sessions involving various tandem schedules of food delivery
without any form of shaping. Both species were exposed to delays that were either
nonresetting or resetting. In a nonresetting procedure (tandem FR1 FT t s), the
responses that occur during the delay interval have no programmed consequences and
actual delays between the last response and delivery of a reinforcer may vary
considerably and be shorter than the programmed delay interval. In a resetting delay,
a tandem FR 1 differential reinforcement of other (DRO) schedule of reinforcement
is incorporated. Under this arrangement, responses during the delay period reset that
interval guaranteeing that the delay remains intact.
Both rats and pigeons acquired responding when resetting and nonresetting
delays were arranged and neither operandum type nor location had an effect on
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acquisition. The authors noted that increasing delays to reinforcement weakened the
behavior that was examined. This was of particular interest to those conducting
research on the effects of drugs on the acquisition of free-operant behavior with
delayed reinforcement, because drug effects are most pronounced when behavior is
weak (Byrne et al., 1996).
Wilkenfield et al. (1992) extended Lattal and Gleeson’s (1990) research by
examining rats’ acquisition of lever response using three delay procedures, resetting,
nonresetting, and stacked, with delays of 4, 8, 16 and 32 s. The procedures used in
the nonresetting and resetting components were similar to those used by Lattal and
Gleeson (1990), except for the delay values and the fact that responses were recorded
on two levers labeled “operative” and “inoperative”. Responses on the operative
lever were reinforced according to one of the delay procedures and values while
responses on the inoperative lever were recorded but had no programmed
consequences. A higher rate of responding on the operative lever is an indication that
the response is specific to that operandum (stimulus control).
The stacked delay involved delayed reinforcement for each response (e.g.,
each response produces a reinforcer). As in a nonresetting procedure, in a stacked
delay, the delay between a response and the delivery of a reinforcer may vary and
may be shorter than the programmed delay. However, unlike the nonresetting and
resetting delay conditions, it ensures a direct relationship between the rate of
responding and rate of reinforcement.
The authors observed acquisition of lever press response in all conditions with
delays of 4, 8, and 16 s for the stacked and nonresetting conditions and with delays of
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4, 8, 16, and 32 s in the resetting condition relative to the control condition.
Furthermore, response rates on the operative lever exceeded rates on the inoperative
lever for all subjects at all delay values, indicating that the operative lever exerted
stimulus control over the rats’ behavior.
Early research on response acquisition with delayed reinforcement involved
rats and pigeons as subjects and appetitive reinforcers. Lattal and Metzger (1994)
examined the effects of delayed visual reinforcement on the behavior of male
Siamese fighting fish (Betta Splendens). The behavior of swimming through a hoop,
which interrupted a photocell beam, initiated an unsignaled delay that was followed
by access to a mirror. Exposure to the image of a male Siamese fighting fish had
previously been shown to act as a reinforcer in this species (Thompson, 1963).
During 90-m sessions the ring apparatus was placed in the tank once a day for 20
sessions. Lattal and Metzger (1994) found that male Siamese fighting fish exposed to
a tandem FR1 DRO 10-s or 25-s schedule of reinforcement exhibited response rates
higher than those exposed to response-independent reinforcers.
Byrne, et al. (1997) extended the work of Stolerman (1971a, 1971b) by
examining the effects of chlorpromazine (0, 2, 6, or 10 mg/kg) on rats’ acquisition of
a lever-press response with delayed reinforcement (0 or 8 s nonresetting). Two
levers, one operative and one inoperative, were present during the 8-h sessions.
Presses on the operative lever produced 4-s access to water and presses on the
inoperative lever had no programmed consequences. Both the number of responses
emitted (rate) and the development of stimulus control by the operative lever was
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assessed. The latter measure provided an appraisal of drug effects that was not
influenced by changes in response rate produced by that drug.
Byrne et al. (1997) found that chlorpromazine produced dose-dependent
decreases in responding on both the operative and inoperative lever. Response
acquisition was seen at doses of 0, 2, and 6 mg/kg but was not evident at 10 mg/kg.
Chlorpromazine at 2 and 6 mg/kg disrupted the development of stimulus control by
the operative lever only when reinforcement was delayed.
LeSage, et al. (1996) examined the effects of d-amphetamine (1.0, 5.6, and
10.0 mg/kg) on rats’ acquisition of a lever-press response with delayed reinforcement
(0, 8, or 16 s) under both resetting and nonresetting conditions. Each rat was placed
in an experimental chamber that contained two levers for a single 8-h session. Both
the number of responses emitted (rate) and development of stimulus control by the
operative lever was assessed. Substantial responding on the operative lever was seen
at all delay values and at all doses of d-amphetamine. Both the acquisition of the
lever-press response and stimulus control was disrupted by the higher doses of damphetamine (5.6 and 10.0 mg/kg) in all conditions while the 1.0 mg/kg dose either
had no effect or enhanced rates of operative-lever responding. Consistent with
findings using the repeated acquisition procedure, the authors showed that damphetamine’s detrimental effects on learning occur at doses that also produce
general behavioral disruption.
Sutphin, et al. (1998) extended the research of Wilkenfield et al. (1992) by
controlling for the possibility that responses on the inoperative lever may be
adventitiously and immediately reinforced by the consequences of responding on the
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operative lever, and therefore spread, through induction, to the operative lever.
Sutphin et al. (1998) examined a two-lever procedure where responses on one lever
(labeled the resetting lever) produced water after a resetting delay (delays were 8, 16,
32 and 64 s) and responses on the other lever (cancellation lever) cancelled a
scheduled reinforcer (this was called the resetting/cancellation condition). The
performance of the aforementioned rats was compared to that of a group of rats
exposed to a two-lever procedure with a resetting lever that and a lever where there
were no consequences for responding (the resetting/no consequences condition).
Each rat was exposed to one 8-h session 24 h after magazine training. The authors
observed differential responding on the two levers in both conditions with an 8-s
delay, but differential responding at delays of 16 and 32 s only occurred with the
resetting/cancellation procedure.
Byrne, Sutphin, and Poling (1998) examined the acquisition, extinction, and
reacquisition of responding with delayed and immediate reinforcement. During
acquisition sessions subjects were exposed to a single resetting lever that delivered
water after delays of 0, 10, 20, and 30 s. Extinction, where no water was delivered,
began after 50 water deliveries. Reacquisition sessions began 18 h after the end of
extinction. These sessions were identical to the acquisition session, except that
extinction was not implemented and sessions lasted 60 m. The authors found that
resistance to extinction decreased with delayed reinforcement. They also found that
responding acquired with delayed reinforcement recovered from extinction slower
and less efficiently than responding that was immediately reinforced.
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Byrne, et al. (2000) examined the effects of acute and neurotoxic exposure of
(+ -) 3, 4- methylenedioxymethamphetamine (MDMA) on rats’ acquisition of a leverpress response, in two experiments. Both experiments used a two-lever procedure
similar to the resetting/cancellation procedure described by Sutphin et al. (1998).
The first experiment examined the acute effects of MDMA on the acquisition
of behavior. Subjects were exposed to a single 8-h session where responses on the
resetting lever were reinforced after delays of 0, 10 and 20 s. Injections of MDMA
(0, 1.0, 3.2, or 5.6 mg/kg) were given 15 m before the start of the responseacquisition sessions. When responses were immediately reinforced, MDMA
produced a dose-dependent increase in the total number of responses and reinforcers
delivered. However, MDMA increased the latency for responding to begin but
neither reduced the total number of responses emitted nor disrupted differential
responding between the resetting and cancellation levers in any of the delay and drug
conditions. The effects of MDMA on response acquisition with delayed
reinforcement were similar to those observed with d- amphetamine, except MDMA
disrupted response acquisition at doses that did not produce behavioral disruption.
The second experiment assessed the effects of neurotoxic exposure to MDMA
on the acquisition of behavior. Half of the subjects were exposed to twice-daily
injections of MDMA at 20 mg/kg for four consecutive days while the remaining
subjects were given twice-daily saline injections for four consecutive days.
Neurochemical analysis revealed a significant decrease in serotonin (5-HT) and its
metabolite (5-hydroxyindole acetic acid) in the rats given daily MDMA injections
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compared to those that received saline injections (this indicated that the dose of
MDMA injected produced neurotoxic effects).
Acquisition testing was the same as in the first experiment. The second
experiment revealed no significant effect of neurotoxic exposure to MDMA on
acquisition at all delay values. The authors cite three possible reasons for this
finding:
First, 5-HT may not play an important role in mediating performance in a given
learning task, or other brain systems may compensate for 5-HT deficits.
Second, the specific assay used may not be sensitive enough to detect the
effects of neurotoxicity. Third, the neurotoxic effects may not be large enough
to cause any detectable behavioral deficits (p. 507).

Because acquisition curves are influenced by the onset and offset of drug effects and
lever-press acquisition is evident in nearly all drug-free rats within 2 h in the absence
of drug, Byrne et al. (2000) recommend using sessions that are no longer than 2 h.

Rationale for the Present Study
The primary aim of the current study was to examine the effects of DM on the
acquisition of a lever-press response with delayed reinforcement, extending the
application of this procedure to the study of opioid drugs. Because the response
acquisition procedure examines the development of novel behavior, it may be relevant
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to the development of new behaviors in young people who are at risk for abusing
dextromethorphan and other drugs. The most common procedures used to examine
drug effects on learning and memory in nonhumans assess drug effects on responses
that are already established and may or may not resemble drug effects on initial
response acquisition. If the findings from response-acquisition studies differ from
findings from other studies and, at the same time, those findings resemble observed
adverse effects in human users, response acquisition procedures may be of
considerable value in the study of drug effects on learning.
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CHAPTER II

METHODS
Subjects
A total of 80 male Sprague-Dawley rats (purchased from Charles River,
Portage, MI) were used in the proposed study. The subjects were approximately 50
days old at the beginning of the study. The subjects were randomly assigned to groups
and housed in pairs in plastic cages (each 24 cm long x 31.5 cm wide x 21 cm high)
located in a colony room maintained on a 12-h light/12-h dark schedule and kept at a
relatively consistent temperature (20-22° C). The rats were restricted to 1 h of access
to Purina Rat Chow (Ralston-Purina, St. Louis) 21 h before the magazine training and
experimental session. Food was available immediately after magazine training and
response-acquisition sessions. Animal care and experimental procedures were
approved by the Institutional Animal Care and Use Committee of Western Michigan
University (Appendix A).
Apparatus

All experimental sessions were conducted in commercially available operant
conditioning chambers, each 31.5 cm long x 25.5 cm wide x 25 cm high (Med
Associates, St. Albans, VT). Each chamber contained two retractable response levers
located 6 cm above the floor on the right and left sides of the front response panel. An
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aperture was located 2 cm above the floor in the middle of the response panel to allow
access to a food cup, which contained an infrared beam that recorded one head-entry
(HE) response each time the beam was broken. A food magazine was programmed to
deliver 45-mg food pellets (BioServ, Frenchtown, NJ). An overhead 28-v house light
provided ambient illumination throughout experimental sessions. Each chamber was
housed in a sound and light-attenuating shell equipped with an exhaust fan that
provides masking noise and ventilation. All experimental events were controlled and
recorded by MED-PC software (v. IV for Windows) operating on an IBM-compatible
personal computer interfaced with the operant chambers using Med Associates
interface equipment.

Drug

Dextromethorphan hydrobromide (Sigma Labs, St. Louis, MO) was dissolved
in distilled water. DM injections were given IP at a volume of 1 ml/kg. The doses
used had previously been shown to disrupt schedule-controlled behavior and
performance on a Morris water maze task (Bane et al., 1996; Taskin, 1986). Doses
used were 40.0, 60.0, and 80.0 mg/kg.
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Procedures

Sixteen rats were randomly assigned to a No Food Control group while the
remaining 64 rats were assigned at random to one of four groups, each comprising 16
animals. After being food deprived for 21 h, all rats received two 90-m magazine
training sessions separated by 24 h. In these sessions, no levers were present in the
chamber, and one pellet was placed in the food receptacle. All HE responses were
recorded. Following the first HE response, the schedule of pellet delivery was
changed to a variable-time (VT) 15-s schedule, under which pellet deliveries occurred
randomly after an average interval of 15 s, independent of the rat’s behavior.
Magazine-training sessions ended after the delivery of 60 food pellets or 90 m,
whichever occurred first. Each subject received 1 h access to food following the
magazine-training session.
Twenty-one hours after the second magazine-training session, each rat was
injected with one of the doses of drug. Thirty-minutes after injection the subjects were
placed in the operant chamber for a 2-h response-acquisition session (Byrne et al.,
2000). This session length was used since levels of DM and DR in the brain and
plasma of Sprague-Dawley rats rise rapidly after and remain consistently high 3 h after
IP injections of DM at 30 mg/kg (Wu et al., 1995). During the response-acquisition
procedure a two-lever resetting/cancellation procedure was arranged as described by
Sutphin et al. (1998) and Byrne et al. (2000). Subjects were placed in the
experimental chambers that contained two levers. One lever was designated the
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reinforcement lever (RL) and the other designated the cancellation lever (CL). A
tandem fixed-ratio 1 DRO schedule was arranged on the RL. Under this schedule,
presses on the RL were reinforced after a delay of 15 s, while presses on this lever
during a delay interval reset the interval. Therefore, obtained delays were equal to
programmed delays. Longer delay values are likely to produce greater variability in
the vehicle group making drug effects more difficult to detect. Responses on the CL
that occurred during a delay interval canceled a scheduled reinforcer. Presses on the
CL at other times were recorded but had no programmed consequences. The location
of the CL and RL was counterbalanced among subjects. All subjects were visually
monitored at 10-m intervals during sessions that followed drug administration in order
to ensure proper functioning of the equipment.
For the 16 rats that were in the No-Food Control group, lever-presses were
recorded but had no programmed consequences during a single 2-h session. If the
delivery of delayed reinforcers strengthens a given rat’s response, that rat should
respond more than rats in the No-Food Control group (where responses were not
reinforced). Therefore, comparing performance of groups that received drug to the
No-Food Control group determined whether rats in the former groups acquired the
lever-press response. Comparing the performance of rats in the groups that received
drug (40, 60, and 80 mg/kg DM) to that of subjects that received vehicle injections (0
mg/kg DM) determined whether doses of DM affected performance relative to that of
untreated animals given the opportunity to learn.
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CHAPTER III

RESULTS

The cumulative number of RL and CL responses, the number of food deliveries
(i.e., Pellets), the number of RL responses that reset the delay interval (i.e., Resets)
and the number of CL responses that canceled a food delivery (i.e., Cancels) were
recorded in 5-s bins for each rat during the acquisition session. Figures 1 through 5
show mean cumulative RL and CL responses, Pellets, Resets, and Cancellations
(acquisition curves) for each group respectively. All groups exhibited accelerated
rates of RL and CL responding across time. Response rates developed more slowly in
the groups that received DM compared to the vehicle control group. The drug groups
exhibited lower rates of RL responding and received fewer pellet deliveries relative to
the vehicle control group. The DM 60 mg/kg group emitted more RL and CL
responses and earned more Pellets than the other drug groups. The DM 60 mg/kg
group showed increased rates of responding on both levers starting about half way
through the session, passing the control group in CL responses and Cancels, while
performing similarly to the control group in RL responses and resets late in the
session. As shown in Figures 1 through 5, the subjects in the DM 80 mg/kg group
started responding later in the session on average than the subjects injected with lower
doses or vehicle. Figures 3 and 4 have been rescaled to best display the data.
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Figure 1. Cumulative records of mean RL responses.
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Figure 2. Cumulative records of mean CL responses.

23

Mean Deliveries
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Figure 3. Cumulative records of mean Pellets.
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Figure 4. Cumulative records of mean Cancels.
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Figure 5. Cumulative records of mean Resets.
Subjects in the DM 0 mg/kg, DM 40 mg/kg, and DM 80 mg/kg groups showed
a dose-dependent decrease in mean total responses on each lever, Pellets, Cancels and
Resets. However, the DM 60 mg/kg group produced more responding on each lever
Cancels and Resets than did the other drug groups. The DM 60 mg/kg group
surpassed the vehicle group in CL responses and Cancels. Figures 6, 7, 8, 9, and 10
show the average RL, CL, Pellets, Cancels and Resets, respectively. Figure 9 has been
rescaled to best display the data. A one-way ANOVA revealed significant differences
in RL responses (F = 3.14, p < 0.04), CL responses (F = 3.35, p < 0.03) and Pellets (F
= 5.23, p < 0.03) between the doses of drugs. A Tukey HSD revealed significant
differences between the vehicle group and the DM 80 mg/kg group in RL responses (q
= 4.20, p < 0.05) and Pellets (q = 5.59, p < 0.05) and between 60 mg/kg and 80 mg/kg
in CL responses (q = 4.30, p < 0.05). One-way ANOVAs revealed no significant
differences between groups in Cancels (F = 0.95, p > 0.42) and Resets (F = 2.28, p >
0.09).
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Figure 6.

Average RL responses for each group. The bars represent standard
errors.
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Figure 7.

Average CL responses for each group. The bars represent standard
errors.
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Figure 8.

Average Pellets for each group. The bars represent standard errors.
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Figure 9.

Average Cancels for each group. The bars represent standard errors.
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Figure 10.

Average Resets for each group. The bars represent standard errors.

The percent of total responses emitted on the RL was computed for each rat
[i.e., Percent = (RL / RL + CL) x 100] during the acquisition session. This measure of
response efficiency quantifies the degree to which the RL exerts stimulus control over
the lever-press response. Furthermore, this measure is not influenced by the rate of
behavior. The majority of responses were emitted on the RL for all conditions. A
one-way ANOVA revealed that DM did not significantly affect the Percent (F = 1.27,
p > 0.29).
A given dose of drug can affect learning by either reducing the total number of
rats that acquired a lever-press response or by slowing the rate of acquisition.
Therefore, two calculations were used to assess the number of rats that acquire the RL
response. The subjects in each experimental group that were determined to have
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acquired the RL response met both of the following conditions: 1) Subjects emitted at
least 36 total responses, the upper limit of the 95% confidence interval around the
mean number of responses on both levers by the No Food Control group (M = 29,
upper limit = 7), and 2) subjects responded a greater number of times on the RL than
the CL (e.g., Snycerski, Laraway, & Poling, 2005). Figure 11 shows the number of
subjects in each group that acquired a lever-press response. A Fisher’s Exact test
revealed that significantly fewer rats injected with 80 mg/kg DM acquired responding
than did subjects that were injected with vehicle (4, N = 32, p < 0.0006). There were
no significant differences between the DM 0 mg/kg and DM 40 mg/kg (4, N = 32, p >
0.05), and DM 60 mg/kg (4, N = 32, p > 0.05) groups.

Number of Subjects

15

10

5

0

0 mg/kg 40 mg/kg 60 mg/kg 80 mg/kg

Dose
Figure 11.

The number of subjects that acquired the lever-press response in each
group.
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A given dose of drug may impair learning by producing side effects that are
incompatible with the lever-press response. Responding on both levers (RL + CL =
Total) was calculated to assess the overall rates of lever pressing in each subject. A
one-way ANOVA revealed a significant difference in Total (F = 3.53, p < 0.02). A
Tukey HSD revealed significant differences between the vehicle group and the DM 80
mg/kg group in Total (q = 4.20, p < 0.05). Figure 12 shows average Total for all
groups.
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Figure 12.

Average total responses on both levers for each group. The bars
represent standard errors.

Variability across subjects may be an indication of differences in the rate that
those subjects metabolized DM. Figures 13 through 16 show cumulative RL data for
all subjects injected with DM at 0, 40, 60, and 80 mg/kg respectively. Figure 16 has
been rescaled to best display the data. There was a wider range of RL responses in the
DM 40 mg/kg and 60 groups than in the DM 80 mg/kg group.
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Figure 13.

Cumulative RL responses the DM 0 mg/kg group.
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Figure 14.

Cumulative RL responses the DM 40 mg/kg group.
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Figure 15.

Cumulative RL responses the DM 60 mg/kg group.
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Figure 16.

Cumulative RL responses the DM 80 mg/kg group.

A given dose of drug may affect behavior by increasing latency to respond
(Latency). The measure of Latency used in the current study is the number of 30-s
bins that passed before the Nth RL response was emitted. Latency to the first, fifth
and tenth response were used in the current study. Figures 17, 18, and 19 show
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average Latency to the first, fifth and tenth response, respectively. A Kruskal-Wallis
one-way analysis of variance revealed a significant difference in Latency to the first
response across groups (H = 15.74, p < 0.0013), 5th response across groups (H =
26.90, p < 0.0001) and the 10th response across groups (H = 26.21, p < 0.0001).
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Figure 17.

Mean latency to emit the first response. The bars represent standard
errors.
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Figure 18.

Mean latency to emit 5 responses. The bars represent standard errors.
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Figure 19.

Mean latency to emit 10 responses. The bars represent standard
errors.
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Dunn’s multiple comparison tests revealed significant differences in Latency to the
fifth response between the vehicle group and the DM 40 mg/kg group; the vehicle
group and the DM 60 mg/kg group; and the vehicle group and the DM 80 mg/kg
group. Tables 1, 2 and 3 show the results of the Dunn’s Multiple Comparison tests for
the latency to the first, fifth and tenth response respectively.

Table 1
Dunn’s Multiple Comparison tests for the latency to the first response.

Dunn's Multiple Comparison Test

Difference in rank sum

P value

DM 0 mg/kg vs. DM 40 mg/kg

-18.53

P < 0.05 *

DM 0 mg/kg vs. DM 60 mg/kg

-19.38

P < 0.05 *

DM 0 mg/kg vs. DM 80 mg/kg

-24.22

P < 0.01 *

DM 40 mg/kg vs. DM 60 mg/kg

0.84

P > 0.05

DM 40 mg/kg vs. DM 80 mg/kg

-5.69

P > 0.05

DM 60 mg/kg vs. DM 80 mg/kg

-4.84

P > 0.05

Significant differences are marked with an asterisk.
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Table 2
Dunn’s Multiple Comparison tests for the latency to emit 5 responses.

Dunn's Multiple Comparison Test

Difference in rank sum

P value

DM 0 mg/kg vs. DM 40 mg/kg

-24.25

P < 0.01 *

DM 0 mg/kg vs. DM 60 mg/kg

-18.97

P < 0.05 *

DM 0 mg/kg vs. DM 80 mg/kg

-32.53

P < 0.001 *

DM 40 mg/kg vs. DM 60 mg/kg

5.281

P > 0.05

DM 40 mg/kg vs. DM 80 mg/kg

-8.281

P > 0.05

DM 60 mg/kg vs. DM 80 mg/kg

-13.56

P > 0.05

Significant differences are marked with an asterisk.
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Table 3
Dunn’s Multiple Comparison tests for the latency to emit 10 responses.

Dunn's Multiple Comparison Test

Difference in rank sum

P value

DM 0 mg/kg vs. DM 40 mg/kg

-22.00

P < 0.01 *

DM 0 mg/kg vs. DM 60 mg/kg

-19.88

P < 0.05 *

DM 0 mg/kg vs. DM 80 mg/kg

-31.50

P < 0.001 *

DM 40 mg/kg vs. DM 60 mg/kg

2.13

P > 0.05

DM 40 mg/kg vs. DM 80 mg/kg

-9.50

P > 0.05

DM 60 mg/kg vs. DM 80 mg/kg

-11.63

P > 0.05

Significant differences are marked with an asterisk.
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CHAPTER IV

DISCUSSION

Latency to Respond

The present study was conducted to assess the effects of DM on the initial
acquisition of a lever-press response with delayed reinforcement. All doses of drug
interfered with learning by significantly increasing Latency and in that sense the study
was successful in extending the use of this procedure to the study of opioids. All three
measures, Latency to first, fifth and tenth response, were affected by all doses of DM.
However, because the first response had not been previously reinforced, latency to the
first response is not an indication of learning. Latency to the fifth and tenth responses
is, however, a valid measure of learning.

Comparing the Response-Acquisition Procedure to Other Assays

Other research methods examining the influence of DM on learning showed
effects at smaller doses than those that significantly affected the dependent measures,
other than Latency, in the current study. For example, Taskin (1986) showed that DM
at 20 and 40 mg/kg disrupted response rates under an FI-45 schedule of
reinforcement. Bane et al. (1996) showed that DM at 30 and 40 mg/kg produced a
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significant impairment of spatial learning. Finally, Dematteis et al. (1998)
demonstrated that DM at 40 mg/kg produced impairment in the performance of a
place learning procedure on a water maze task. The aforementioned assays examined
the acquisition of negatively reinforced behavior and any effect of DM could be due to
the anxiolytic action of DR (Dematteis et al., 1998). However, as mentioned above,
none of these studies examined the initial acquisition of positively reinforced behavior.
The detrimental effects of DM on the acquisition of positively reinforced
behavior is of particular concern since the typical recreational users of the drug are
adolescents and young adults and disruption of learning is particularly important
during these years. In humans, drug use during adolescence has been shown to disrupt
the acquisition of cognitive skills that may be important to functioning in interpersonal
and intrapersonal domains (Schier & Botvin, 1995).

Behavioral Disruption

Only the highest dose of DM produced significant effects on RL responses, CL
responses, Pellets, and Acquisition, a dose that also produced noticeable behavioral
disruption throughout the session. Visual inspection revealed subjects in the DM 80
mg/kg group demonstrated obvious signs of ataxia (awkward and jerky movement,
falling on side and difficulty walking on bars in the experimental chamber). These
disruptions were not seen after injections of the lower doses. It is reasonable to
assume that the PCP-like activity of DR affected subjects in the current study given
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that DM was administered via IP injection with a 30-m post injection period. As
mentioned above, in Sprague-Dawley rats, brain concentrations of DR rise rapidly and
remain consistently high 3 h after IP administration of DM at 30 mg/kg (Wu et al.,
1995). Dematteis et al. (1998) documented similar effects on a water-maze task after
injections of high doses of DM and DR. Rats injected with DM 40 mg/kg and DR 20
and 40 mg/kg showed only slight to moderate levels of behavioral disruption, as
measured in an open field experiment. However, these subjects exhibited noticeable
disruption (floating before swimming, jumping off the escape platform, swimming
along the sidewalls and attempting to run up sidewalls) when performing on a water
maze task. The authors attributed this to ataxia and the anxiolytic action of DR
(which may reduce motivation to find the escape platform), as well as sedation
produced by DM.
Sedation produced by DM may also contribute to the significant effects
observed at the highest dose in the current study. DM is rapidly metabolized and only
low concentrations of DM may have been active in subjects during experimental
sessions in the current study. The fact that significant effects on RL, CL, Pellets,
Cancels, Percent, and Acquisition were only seen at the 80 mg/kg dose may be due to
the need to achieve a certain DM threshold concentration before an effect can be
observed (A. Somogyi, personal communication, February 18, 2005).
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Locomotor Activity

In the present study, a reduction in Total and increase in Latency was observed
in the DM 40 mg/kg and 80 groups. However, subjects in the DM 60 mg/kg group
demonstrated an increased Total and shorter Latency than other experimental groups,
although the difference was not statistically significant. These findings may be related
to the dose-dependent effects of DR, an active metabolite of DM, on locomotor
activity. For example, Wu et al. (1995) showed a significant increase in locomotor
activity in rats given IP injections of DM at 60 mg/kg compared to those given saline.
No significant effects were observed after injections of lower doses (15 and 30
mg/kg). Dematteis et al. (1998) observed a reduction in locomotor activity after
injections of DR at 20 and 30 mg/kg while 40 mg/kg increased locomotor activity. It
is possible that DM at 60 mg/kg affected Total and Latency by producing an increase
in locomotor activity in the current study. A dose of drug that increases locomotion,
without producing side effects that are incompatible with responding, increases the
probability that subjects will come in contact with the lever reducing Latency and
increasing Total.

Lack of Effect at Lower Doses

As mentioned earlier, doses of DM that failed to disrupt acquisition
significantly in the current study had been shown to produce low levels of behavioral
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disruption in other studies. For example, injections of DM at 40 mg/kg produced
slight motor disturbances in rats (Bane et al., 1996; Dematteis et al., 1998) and
injections of DM at 30 to 60 mg/kg significantly reduced FR responding in substitution
tests involving a saline vs. PCP discrimination (Nicholson, 1999). In the current study,
subjects in the DM 60 mg/kg and 40 mg/kg groups did not exhibit the signs of ataxia
observed in the DM 80 mg/kg group. Also, the responding of subjects in the DM 40
mg/kg and 60 mg/kg groups on RL, CL, Pellets, Cancels, Percent, and Acquisition did
not significantly differ from the control group. There are two possible explanations for
a lack of a significant effect at the lower doses tested. First, DM may not disrupt
acquisition of RL, CL, Pellets, Cancels, Percent, and Acquisition at these doses.
Second, the lack of statistical significance at the lower doses may be due to withingroup variability in the rate that subjects metabolized DM.

Suggestions for Further Research

DM Combined with Other Drugs
DM is often abused in combination with other OTC substances. Nevin (2004)
noted that the use of DM in combination with other drugs is the rule rather than the
exception. DM has been used recreationally in combination with diphenhydramine
(Jun, Thorndike & Schindler, 2004), pseudoephedrine (Narin & Diaz, 2001), and
chlorpheniramine maleate (Nevin, 2004), typically because OTC preparations that
contain DM also contain these substances.
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DM also has been used in combination with MDMA. In a sample of street
drugs sold as MDMA, the most common drug identified, other than MDMA, was DM
(Baggott, Heifets, Jones & Mendelson, 2000). Occasionally, DM is mixed with heroin
to increase its pharmacological effects (Cranston & Yoast, 1999).
The continued abuse of OTC drugs by humans and use of street drugs laced
with DM warrants further study of the behavioral effects of combinations of these
drugs. Research on the behavioral effects of DM in combination with other drugs may
yield different results from findings generated by previous research examining this
drug. For example, Jun et al. (2004) found that rats would self-administer DM and
diphenhydramine in combination but not when either drug was given alone.

Route of Administration
The route of administration of DM may influence the behavioral response to
this drug. Because the effects of DR resemble those of PCP, subjects that convert DM
to DR more readily would be more likely to exhibit PCP-like effects (Dematteis et al.,
1998; Funck-Brentano et al., 1992; Kerry, Somogyi, Mikus, & Bochner, 1993). DM
eventually is metabolized to 3-hydroxymorphinan via two separate pathways. Kerry et
al. (1993) describe this process:
The O-demethylation of DM to dextrorphan (DR) is catalyzed by the
polymorphic CYP2D6 (cytochrome P4502D6) isozyme in humans. DR is
further metabolized by N-demethylation to 3-hydroxymorphinan (3OHM) and
both metabolites are then conjugated. DM is also N-demethylated to 3-
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methoxymorphinan (3MM), which is further O-demethylated to 3OHM. (p.
833)
Variability across humans has been observed in the rate that DM is converted
to DR. Pfaff, Briegel and Lamprecht (1983) observed average plasma levels of DR
ranging from 11.7 to 690 ng/ml in adult human subjects 2 h after oral administration of
DM (25 mg). Kennedy, Abdel-Rahman, Kashuba, and Leeder (2004) noted that the
metabolic rates for DM of children between the ages 3 and 8 years, who were
determined to be extensive metabolizers, did not stabilize until 4-h after oral
administration. The authors noted that longer periods of time might be needed before
metabolic rates stabilize in subjects who are poor metabolizers.
Differences in DM metabolism also have been documented in different strains
of rats. For example, female Dark Agouti rats are deficient in the cytochrome P459
enzyme, which catalyses the O-demethylation of DM to DR in Sprague-Dawley rats
(Ishmael, Franklin, & Murray, 1998). Dark Agouti and Sprague-Dawley rats are
considered poor metabolizers and extensive metabolizers of DM, respectively. Kerry
et al. (1998) observed a wide range in the rates that three Sprague-Dawley rats
metabolized DM to DR (25.01 to 52.43 nanomoles formed per milligram of
microsomal protein per hour). Although the extent that variation in the rate that
subjects metabolize DM affects learning has not been assessed, it certainly is plausible
that this variable affected the results of the present study.
The current study used the IP route of administration in order to enhance the
biotransformation of DM to DR. The effects that administration of DM may have via
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the SC route were not examined in the current study due to the limited availability of
subjects. As mentioned above, the lack of an effect at the lower doses may be due to
the need to achieve a certain threshold concentration of DM before an effect can be
observed. Injecting DM via the SC route of administration produces a different
metabolic pattern from the IP route, thus increasing the bioavailability of DM (Wu et
al., 1995). Therefore, the use of the SC route of administration would likely produce
different results from those of the current study.
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APPENDIX A
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A copy of the Institutional Animal Care and Use Committee is on file in The
Graduate College, Western Michigan University.
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